GSK5784283 for Nasal Polyps

(PERSISTCRSwNP1 Trial)

This trial tests a new treatment called GSK5784283 for individuals with chronic rhinosinusitis with nasal polyps (CRSwNP), which leads to ongoing nasal congestion and loss of smell. The researchers aim to determine if adding this treatment to usual care reduces symptoms and ensures safety. Participants will receive either the new treatment or a placebo, both alongside their standard care. The study seeks individuals with physician-diagnosed CRSwNP for over a year, who have undergone surgery or steroid treatments, and regularly use nasal sprays. As a Phase 3 trial, this treatment is in the final step before FDA approval, providing an opportunity to contribute to its potential availability for wider use.

Research has shown that GSK5784283 targets a protein called TSLP, linked to inflammation, to treat nasal polyps. This protein may play a role in conditions like asthma and nasal polyps. Although specific safety data for GSK5784283 in nasal polyps is not yet available, the treatment is currently in Phase 3 trials. This phase typically involves many participants and aims to confirm the treatment's efficacy and safety.

Most treatments for nasal polyps, like corticosteroids and surgery, work by reducing inflammation or physically removing the polyps. However, GSK5784283 works differently, targeting the underlying causes of polyp formation. This new treatment is believed to modulate the immune response in a way that could lead to more effective and lasting results. Researchers are excited because it offers a potential new avenue for relief, especially for patients who don't respond well to existing options.

Research has shown that GSK5784283, which participants in this trial may receive, may help treat chronic rhinosinusitis with nasal polyps (CRSwNP). While not everyone experiences improvement, many report less congestion and smaller polyps. Some studies found significant improvements in patient-reported outcomes, as measured by tests like the SinoNasal Outcome Test, which assesses symptom severity. Biologic therapies, such as GSK5784283, offer a new treatment option for those with recurring polyps, especially if they've had previous surgery. Although these treatments don't work for everyone, they often provide relief for many.⁶⁷⁸⁹¹⁰